Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 13 results.
User Information
Export Records
  1. 1.   Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
  2. Sun, K.; Wilkins, D. E. C.; Anver, M. R.; Sayers, T. J.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Weiniak, L. A.; Murphy, W. J.
  3. Blood. 2005, NOV 1; 106(9): 3293-3299.
  1. 2.   Coactivators and corepressors of NF-kappa B in I kappa Beta alpha gene promoter
  2. Gao, Z. G.; Chiao, P.; Zhang, X.; Zhang, X. H.; Lazar, M. A.; Seto, E.; Young, H. A.; Ye, J. P.
  3. Journal of Biological Chemistry. 2005, JUN 3; 280(22): 21091-21098.
  1. 3.   Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages
  2. Cho, H.; Lasco, T. M.; Allen, S. S.; Yoshimura, T.; McMurray, D. N.
  3. Infection and Immunity. 2005, MAR; 73(3): 1367-1376.
  1. 4.   Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages
  2. Skwor, T. A.; Cho, H. S.; Cassidy, C.; Yoshimura, T.; McMurray, D. N.
  3. Journal of Leukocyte Biology. 2004, DEC; 76(6): 1229-1239.
  1. 5.   BCL-3 and NF-kappa B p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages
  2. Wessells, J.; Baer, M.; Young, H. A.; Claudio, E.; Brown, K.; Siebenlist, U.; Johnson, P. F.
  3. Journal of Biological Chemistry. 2004, NOV 26; 279(48): 49995-50003.
  1. 6.   Nitric oxide, a mediator of inflammation, suppresses tumorigenesis
  2. Hussain, S. P.; Trivers, G. E.; Hofseth, L. J.; He, P. J.; Shaikh, I.; Mechanic, L. E.; Doja, S.; Jiang, W. D.; Subleski, J.; Shorts, L.; Haines, D.; Laubach, V. E.; Wiltrout, R. H.; Djurickovic, D.; Harris, C. C.
  3. Cancer Research. 2004, OCT 1; 64(19): 6849-6853.
  1. 7.   Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells
  2. Fonteneau, J. F.; Larsson, M.; Beignon, A. S.; McKenna, K.; Dasilva, I.; Amara, A.; Li, Y. J.; Lifson, J. D.; Littman, D. R.; Bhardwaj, N.
  3. Journal of Virology. 2004 78(10): 5223-5232.
  1. 8.   An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection
  2. Thio, C. L.; Goedert, J. J.; Mosbruger, T.; Vlahov, D.; Strathdee, S. A.; O'Brien, S.; Astemborski, J.; Thomas, D. L.
  3. Genes and Immunity. 2004 5(4): 294-300.
  1. 9.   Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography
  2. Castle, P. E.; Phillips, T. M.; Hildesheim, A.; Herrero, R.; Bratti, M. C.; Rodriguez, A. C.; Morera, L. A.; Pfeiffer, R.; Hutchinson, M. L.; Pinto, L. A.; Schiffman, M.
  3. Cancer Epidemiology Biomarkers & Prevention. 2003 12(12): 1449-1456.
  1. 10.   Nitric oxide does not mediate but inhibits transformation and tumor phenotype
  2. Dhar, A.; Brindley, J. M.; Stark, C.; Citro, M. L.; Keefer, L. K.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2003 2(12): 1285-1293.
  1. 11.   Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H
  2. Gosselin, P.; Mason, L. H.; Willette-Brown, J.; Ortaldo, J. R.; McVicar, D. W.; Anderson, S. K.
  3. Journal of Leukocyte Biology. 1999 66(1): 165-171.
  1. 12.   Il-8 Is an Essential Mediator of the Increased Delayed-Phase Vascular Permeability in Lps-Induced Rabbit Pleurisy
  2. Fukumoto, T.; Matsukawa, A.; Yoshimura, T.; Edamitsu, S.; Ohkawara, S.; Takagi, K.; Yoshinaga, M.
  3. Journal of Leukocyte Biology. 1998 63(5): 584-590.
  1. 13.   The Ly-49 Family - Regulation of Cytokine Production in Murine Nk Cells
  2. Ortaldo, J. R.; Mason, L. H.; Gregorio, T. A.; Stoll, J.; Winklerpickett, R. T.
  3. Journal of Leukocyte Biology. 1997 62(3): 381-388.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel